Up 10%: Why the Polynovo share price is popping today

Polynovo shares are rocketing for the second day in a row…

| More on:
Shot of a young scientist using a digital tablet while working in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's looking like another strong day for ASX shares and the S&P/ASX 200 Index (ASX: XJO) so far this Tuesday. At the time of writing, the ASX 200 has gained a healthy 0.38%, putting the index back over 7,500 points. But let's discuss the Polynovo Ltd (ASX: PNV) share price.

Polynovo shares are putting the gains of the broader market to shame so far this Tuesday. At present, the ASX 200 healthcare stock is up a whopping 8.16% at $1.88 a share. That's after Polynovo stock lifted as high as $1.92 soon after market open this morning (up more than 10% at the time).

So what's going on with this healthcare company today that is resulting in these kinds of stellar share price moves?

Polynovo shares spike 10% on bumper trading result

It seems that these gains can be put down to the trading update Polynovo released yesterday during trading hours.

As we briefly touched on yesterday afternoon, this indicative trading update (covering the first half of FY2024) was probably responsible for Polynovo shares' near-10% rise for Monday's session.

It's not too hard to see why.

Polynovo told investors that its total global revenue for the first half of FY2024 came in at 48.8 million, up 65.6% from the $29.5 million recorded at this time last year.

The company also achieved a record sales revenue of $42.2 million (up 54.9%), as well as U.S. sales of $32.2 million (up 41.7%).

Rest of world sales rocketed 122.2% to $10 million.

The company also reported positive earnings before interest, tax, depreciation and amortisation (EBITDA), and a net profit after tax (NPAT) for the period. Excluding non-cash items, Polynovo achieved an underlying EBITS of $3.6 million for the period.

Polynovo chair David Williams had this to say on these numbers:

While I view profit as a 'nice to have', I am more excited by the significant near-term revenue growth possibilities from our expanding geographic footprint and the new ways surgeons have found to use our products. Profits will drop naturally out of the drive and success in expanding our geographies and products.

Given most of yesterday's strong share price gains came after Polynovo released this update, it seems that we can thank it for both those gains, and the further rise we are seeing today.

But despite these gains, the Polynovo share price remains down by 25.8% over the past 12 months.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PolyNovo. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two happy scientists analysing test results in a lab
Share Market News

Here's how the ASX 200 market sectors stacked up last week

ASX healthcare shares were strongest among the 11 market sectors last week.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

ResMed share price jumps 10% on strong quarterly update

ResMed has impressed the market with its third-quarter update.

Read more »

Happy healthcare workers in a labs
Healthcare Shares

Up 74% in 6 months, guess which ASX 200 healthcare stock just hit another all-time high

This company has busily deployed cash over the past six months while growing at a phenomenal pace.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Broker says this ASX biotech stock could almost double in value

Bell Potter is feeling very bullish about this risky stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Woman going for a scan reassured by doctor
Healthcare Shares

How AI could boost this ASX 300 healthcare stock

The Firetrail investment management team see AI providing a 'material tailwind' for this stock.

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is the ResMed share price diving 5% today?

Weight loss wonder drugs are weighing heavily on this stock.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Why is the Telix share price jumping 15% to a record high?

This healthcare stock is scaling new heights on Thursday. But why?

Read more »